Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 366.00 | 328.00 | 1.1159 | 1.2109 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 543.00 | 328.00 | 1.6555 | 2.1715 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 372.00 | 328.00 | 1.1341 | 1.2441 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 153.73 | 296.00 | 328.00 | 0.9024 | 0.8208 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 312.50 | 153.73 | 136.00 | 328.00 | 0.4146 | -0.1060 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 250.00 | 328.00 | 0.7622 | 0.5601 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 658.00 | 794.00 | 0.8287 | 0.7329 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 625.00 | 320.09 | 755.00 | 794.00 | 0.9509 | 0.9246 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 320.09 | 849.00 | 794.00 | 1.0693 | 1.1049 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 906.00 | 794.00 | 1.1411 | 1.2118 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 882.00 | 794.00 | 1.1108 | 1.1670 |
| BT-20 | Lapatinib | 10 | uM | 9 | 625.00 | 320.09 | 456.00 | 794.00 | 0.5743 | 0.3100 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 1079.00 | 794.00 | 1.3589 | 1.5273 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 320.09 | 1016.00 | 794.00 | 1.2796 | 1.4139 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 1125.00 | 794.00 | 1.4169 | 1.6091 |
| BT-20 | Lapatinib | 1 | uM | 9 | 625.00 | 320.09 | 954.00 | 794.00 | 1.2015 | 1.3007 |
| BT-20 | Linsitinib | 10 | uM | 9 | 625.00 | 320.09 | 778.00 | 794.00 | 0.9799 | 0.9692 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 823.00 | 794.00 | 1.0365 | 1.0555 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 846.00 | 794.00 | 1.0655 | 1.0992 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 1064.00 | 794.00 | 1.3401 | 1.5005 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 802.00 | 794.00 | 1.0101 | 1.0154 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 625.00 | 320.09 | 526.00 | 794.00 | 0.6625 | 0.4608 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 771.00 | 794.00 | 0.9710 | 0.9556 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 625.00 | 320.09 | 1046.00 | 794.00 | 1.3174 | 1.4681 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 811.00 | 794.00 | 1.0214 | 1.0326 |